Covid-19 is an illness that appeared in China between the end of December 2019 and thebeginning of 2020 after several cases of pneumonia of undetermined etiology were reportedin the Hubei province in central China. These are caused by a previously unknowncoronavirus, initially named 2019-nCoV then SARS-CoV-2, which was identified on January7, 2020 in the Bronchoalveolar Lavage (BAL) of patients hospitalized in China. As for thefirst European cases, they were diagnosed in France on January 24, 2020.A Chinese study published in April 2020 (4) concerning adult patients showed that 14% ofthese cases could be defined as severe and that 5% of cases could be defined as critical.Another Chinese study showed that all children, regardless of age, could be infected andthat asymptomatic, mild and moderate cases accounted for more than 90% of cases.In France, the Covid-19 epidemic hit Alsace hard from March 2020, mainly due to thecluster formed by the evangelical assembly of the Christian Open Door Church taking placefrom February 17 to 21 in Mulhouse in the Haut-Rhin.Thus, it is interesting to study pediatric patients hospitalized for Covid-19 in Alsaceduring 2020 in order to discover the clinical characteristics of these patients.
The main objective of this study is to retrospectively describe the clinical, biological
and radiological characteristics of pediatric patients hospitalized for Covid-19 in
Alsace in 2020-2021, both in conventional service and in continuing care or intensive
care.
Inclusion Criteria:
- Subject aged from 1 month to 18 years
- Hospitalized for Covid-19 in conventional service, continuing care or intensive care
for Covid-19 or in whom SARS-CoV-2 infection was strongly suspected during the allat
period from January 1, 2020 to December 31, 2021
- Subject who has not expressed, after information, his opposition to the reuse of his
data for the purposes of this research
- Parental authority having not expressed, after information, their opposition to the
reuse of their data for the purposes of this research.
Exclusion Criteria:
- Subject or their parental authority having expressed their opposition to
participating in the study
Centre de Ressources et de Compétences de la Mucoviscidose (CRCM) - CHU de Strasbourg - France
Strasbourg, France
Investigator: Laurence WEISS, MD
Contact: 33 3 88 12 83 95
laurence.weiss@chru-strasbourg.fr
Laurence WEISS, MD
33 3 88 12 83 95
laurence.weiss@chru-strasbourg.fr
Not Provided